Welcome to the Knowledge Center

Choose from a variety of resources to learn more about the fundamentals of laboratory science, uncover new methodologies like Total Value of Ownership and gain ideas to propel your healthcare institution forward

 

DISCOVER THE IMPACT OF 
STRONG PARTNERSHIPS

Explore best practice examples of integrated clinical care teams that demonstrate how identifying challenges and addressing them in collaborative ways can lead to measurably better healthcare performance. 

Learn from Industry Experts

Watch our webinars to gain insight into industry trends, medical discoveries, health technology and much more.

 

 

Resources that advance
your laboratory

Abbott has developed a library of digital resources to help you in your work. Use these publications to keep abreast of the latest information in laboratory science, important therapeutic areas, and how Abbott has contributed to the industry.

COVID-19 white Papers
 

Reimagining the Health System in the Wake of the COVID-19 Pandemic

 

 

 

 

 

 

Health-Systems-Leadership-icon_200x190.png

Health System CEOs from across the US discovered three common themes, regardless of location and incidence of COVID-19, that health systems and their communities faced and are continuing to face during this pandemic. Find out why we need to focus on:

  • Building the Community
  • Building Confidence
  • Building the Future

 

Read The White Paper 
 

 

 

creating value in the lab  
 

TOTAL VALUE OF OWNERSHIP

 

 

 

Total Cost of Ownership

 

 

  

 

 

 

 

 

Analyzing the laboratory with a Total Value of Ownership (TVO) methodology can unlock a wealth of possibilities to deliver value. Learn how three laboratories from around the world applied TVO to help them to reach their goals.

Explore total value of ownership 

 

Total Cost of Ownership (TCO) provides a structured approach to analyzing all direct and indirect instrument costs. Discover how several analytic platforms compare in three key areas: maintenance time, processing time and utility consumption. 

Read the Total Cost of Ownership White Paper 

 

Infectious Disease
 

The Economist:
Egpyt's Path to Eliminating Hepatitis

 

 

 

THE ECONOMIST:
TAKING AIM: THE POLICY RESPONSE TO VIRAL HEPATITIS IN UGANDA

 

 

 

THE ECONOMIST:
PAKISTAN RENEWS FIGHT AGAINST BURGEONING HEPATITIS BURDEN

The prevalence of Hepatitis C in Egypt was unlike any other country in the world. Discover why Egypt now appears to be on the path to successfully eliminating viral Hepatitis and how their approach can offer valuable lessons to other countries.

Read the White paper

 

There is evidence that viral Hepatitis is a growing danger in Uganda. However, a lack of data made it difficult to create a strategic plan for the way forward. Learn about Uganda's multifaceted policy response to address this important issue.

Read the White paper

 

The scale of Hepatitis C in Pakistan required elevation to a public health priority after past inadequate action, while Hepatitis B declined with a successful vaccination program. Explore Pakistan's renewed commitment to fighting both Hepatitis C and B.

Read the White paper
BIOTIN INTERFERENCE
 

Scientific updates Assessment of on-market assays, FDA Recommendations and FAQ

 

 

 

 

 

 

Stay up-to-date with the latest regulations and medical uses for Biotin and develop your knowledge on assay interference that has the potential to result in false results that can be critical to patient safety and your laboratory practice.

Read about Biotin Interference
 

 

  Biotin-home-image.png

Learn more about Biotin risks and find additional resources to help you stay aware of adverse events.

Visit the Biotin Interference page
Archive
 

 View our archive collection of publications that can be used to build upon current knowledge or aid in additional research for in-lab personel or management. 

 
Publication Description
DIABETES
Assessing Analytical Quality of HbA1c Assays Using Sigma Metrics
HbA1c is a critical assay as a result of the worldwide diabetes epidemic. Read the study to view the analytical performance of four HbA1c commercial assays using accuracy based grading and Sigma metrics.

Critical education for your team

Build key laboratory competencies to better serve physicians and patients with our learning guides.

 

Join the conversation

Follow the Abbott Diagnostics LinkedIn channel for the latest news from our company and within the in vitro diagnostics industry.

©2016 Abbott,  Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

All ARCHITECT analyzers, CELL-DYN Ruby, CELL-DYN Sapphire, and CELL-DYN 3200, 3500/3700 instruments are Class I laser products. ACCELERATOR APS, and ACCELERATOR a3600 are Class II laser products.

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

DO YOU WISH TO CONTINUE AND EXIT THE CORE LABORATORY WEBSITE?

Content is not under the control of corelaboratory.abbott.

Yes No